In this study, researchers from the Cancer Research UK Cambridge Institute (UK) used whole-genome sequencing to analyze CSF from 13 glioma patients. By doing so, the team detected the copy number alterations in glioma using short cell-free DNA.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.